Free Trial
OTCMKTS:CAPS

Capstone (CAPS) Stock Price, News & Analysis

Capstone logo
$1.94 +0.03 (+1.57%)
As of 05/23/2025 04:00 PM Eastern

About Capstone Stock (OTCMKTS:CAPS)

Key Stats

Today's Range
$1.90
$2.00
50-Day Range
$1.66
$2.92
52-Week Range
$1.58
$16.18
Volume
71,884 shs
Average Volume
709,744 shs
Market Capitalization
$306,520.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone's stock was trading at $2.24 at the beginning of 2025. Since then, CAPS stock has decreased by 13.4% and is now trading at $1.94.
View the best growth stocks for 2025 here
.

Capstone Holding Corp. (OTCMKTS:CAPS) released its earnings results on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company earned $2 million during the quarter.

Capstone's quiet period expired on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its initial public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were restricted from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Capstone investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
8/13/2018
Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CAPS
Employees
38
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.42 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
90,000
Market Cap
$306,520.00
Optionable
Not Optionable
Beta
-0.82

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:CAPS) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners